Perrigo Tops $2B in Sales in 2009
Perrigo Company, maker of generic prescription drugs and store brand over-the-counter drugs, posted record earnings and cash flow numbers Tuesday, topping $2 billion in sales for the first time.

The company saw a 16% increase in revenue for the fiscal year ending June 27, 2009. The year's sales totaled $2,006,862,000,versus $1,729,921,000 the previous year.

In a release announcing the company's financial performance, CEO Joseph C. Papa also announced the company's increased stake in a manufacturing facility in Mumbai, India.

The release went to to predict 2010 earnings per share to increase from seven to 13 percent.